Quantcast

Latest Minimaze procedure Stories

2011-03-04 11:12:00

ROYAL OAK, Mich., March 4, 2011 /PRNewswire/ -- Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay. Phillip Robinson, M.D., cardiovascular surgeon, Brian Williamson, M.D. and Ilana...

2011-01-24 18:40:00

MARLBOROUGH, Mass., Jan. 24, 2011 /PRNewswire/ -- CardioFocus announced that two "live cases" using its Endoscopic Ablation System were recently conducted. The first live case was a satellite transmission performed at Centro Cardiologico Monzino in Milan, Italy; broadcast to the 16th Annual Boston Symposium on Atrial Fibrillation in Boston, MA. Several pioneers in the treatment of atrial fibrillation served as moderators for this exciting educational presentation, providing perspective on...

2011-01-10 16:20:00

DALLAS, Jan. 10, 2011 /PRNewswire-USNewswire/ -- Physicians at Baylor Jack and Jane Hamilton Heart and Vascular Hospital are the first in North Texas to offer the Arctic Front® Cardiac CryoAblation Catheter system, the first and only cryoballoon in the United States indicated to treat drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder that affects millions of Americans. Recently approved by the U.S. Food and Drug...

2011-01-10 07:03:00

MORRISVILLE, N.C., Jan. 10, 2011 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias. "nContact's progressive technology and our...

2010-12-07 07:00:00

SAN RAMON, Calif., Dec. 7, 2010 /PRNewswire/ -- Estech announced today that it has completed $8.5 million in equity financing to pursue further development of its minimally invasive cardiac ablation surgical platform. Investors participating in the financing include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and Tullis Health Investors. Over the last two years, Estech has raised over $28 million in equity financing to fund its innovation and business development...

2010-11-10 07:30:00

MORRISVILLE, N.C., Nov. 10, 2010 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it has closed a $16 million Series D round of equity financing, bringing the company's total financing since inception to $42.4 million. The financing was led by existing investors, Harbert Venture Partners, and included new investors, ZMV Associates. The company expects this financing to support its three ongoing clinical trials, further product...

2010-09-21 07:03:00

MORRISVILLE, N.C., Sept. 21 /PRNewswire/ -- During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches. He called for the cardiac surgeons in attendance to...

2010-09-13 07:03:00

MORRISVILLE, N.C., Sept. 13 /PRNewswire/ -- The Convergent Procedure, a novel approach to treat atrial fibrillation (AF), enabled by epicardial ablation products from nContact Surgical, Inc. (nContact), was highlighted at the Techno-College Atrial Fibrillation Session of the EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting in Geneva, Switzerland. More than 1,000 medical professionals attended the 2010 Techno-College Programme to receive an update on the latest...

2010-06-23 07:02:00

RALEIGH, N.C., June 23 /PRNewswire/ -- nContact Surgical, Inc. (nContact) reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons (ISMICS) meeting in Berlin, Germany, indicated that after one year 80%...

2010-05-14 06:30:00

RALEIGH, N.C., May 14 /PRNewswire/ -- nContact Surgical, Inc. (nContact) announced today the presentation of data collected from 43 patients as a result of a closed chest convergent atrial fibrillation (AF) procedure at the Heart Rhythm Society 2010 Conference in Denver, Colorado. Results reported from Dr. Di Biase et al. indicated that the Convergent procedure, which combines epicardial and endocardial ablation via a minimally invasive, fully closed chest approach, enabled 81% of the...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related